Gland Pharma Limited · NSE: GLAND · BSE: 543245

Gland Pharma

Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 10 Aug 2026.

Q1 FY27 · Consolidated

Revenue
1,800.27₹ Cr
+19.6% vs year ago
Net profit
316.96₹ Cr
+47.1% vs year ago
EPS, basic
19.23₹
+47.0% vs year ago
Net margin
17.6%
+3.3 pts vs year ago
Revenue₹ crore · consolidated · last 12 quarters
Q2 FY24: ₹1,373.42 CrQ3 FY24: ₹1,545.15 CrQ4 FY24: ₹1,537.45 CrQ1 FY25: ₹1,401.71 CrQ2 FY25: ₹1,405.83 CrQ3 FY25: ₹1,384.05 CrQ4 FY25: ₹1,424.91 CrQ1 FY26: ₹1,505.62 CrQ2 FY26: ₹1,486.88 CrQ3 FY26: ₹1,695.36 CrQ4 FY26: ₹1,742.79 CrQ1 FY27: ₹1,800.27 CrQ3 ’24Q1 ’25Q3 ’25Q1 ’26Q3 ’26Q1 ’27
Net profit₹ crore · consolidated · last 12 quarters
Q2 FY24: ₹194.08 CrQ3 FY24: ₹191.86 CrQ4 FY24: ₹192.42 CrQ1 FY25: ₹143.76 CrQ2 FY25: ₹163.53 CrQ3 FY25: ₹204.69 CrQ4 FY25: ₹186.54 CrQ1 FY26: ₹215.48 CrQ2 FY26: ₹183.68 CrQ3 FY26: ₹261.48 CrQ4 FY26: ₹366.68 CrQ1 FY27: ₹316.96 CrQ3 ’24Q1 ’25Q3 ’25Q1 ’26Q3 ’26Q1 ’27

Quarter by quarter

Consolidated · ₹ crore
QuarterRevenueYoYNet profitYoYEPS (₹)Filed
Q1 FY27Apr–Jun 20261,800.27+19.6%316.96+47.1%19.2310 Aug 2026
Q4 FY26Jan–Mar 20261,742.79+22.3%366.68+96.6%22.2615 May 2026
Q3 FY26Oct–Dec 20251,695.36+22.5%261.48+27.7%15.8728 Jan 2026
Q2 FY26Jul–Sep 20251,486.88+5.8%183.68+12.3%11.1503 Nov 2025
Q1 FY26Apr–Jun 20251,505.62+7.4%215.48+49.9%13.0805 Aug 2025
Q4 FY25Jan–Mar 20251,424.91−7.3%186.54−3.1%11.3220 May 2025
Q3 FY25Oct–Dec 20241,384.05−10.4%204.69+6.7%12.4203 Feb 2025
Q2 FY25Jul–Sep 20241,405.83+2.4%163.53−15.7%9.9304 Nov 2024
Q1 FY25Apr–Jun 20241,401.71+16.0%143.76−25.9%8.7307 Aug 2024
Q4 FY24Jan–Mar 20241,537.45+95.9%192.42+144.6%11.6823 May 2024
Q3 FY24Oct–Dec 20231,545.15+64.7%191.86−17.3%11.6515 Feb 2024
Q2 FY24Jul–Sep 20231,373.42+31.5%194.08−19.5%11.7807 Nov 2023
Q1 FY24Apr–Jun 20231,208.69+41.1%194.10−15.3%11.7907 Aug 2023
Q4 FY23Jan–Mar 2023785.01−28.8%78.68−72.5%4.7819 May 2023
Q3 FY23Oct–Dec 2022938.29−11.8%231.95−15.0%14.0824 Jan 2023
Q2 FY23Jul–Sep 20221,044.40−3.3%241.24−20.1%14.6527 Oct 2022
Q1 FY23Apr–Jun 2022856.90−25.7%229.17−34.6%13.9320 Jul 2022
Q4 FY22Jan–Mar 20221,103.01+24.2%285.90+9.8%17.4020 May 2022
Q3 FY22Oct–Dec 20211,063.33—273.03—16.6221 Jan 2022
Q2 FY22Jul–Sep 20211,080.47—302.08—18.3723 Oct 2021
Q1 FY22Apr–Jun 20211,153.90—350.65—21.4122 Jul 2021
Q4 FY21Jan–Mar 2021887.75—260.41—15.9318 May 2021
Standalone results
Standalone · ₹ crore
QuarterRevenueYoYNet profitYoYEPS (₹)Filed
Q1 FY27Apr–Jun 20261,286.64+23.9%364.39+35.3%22.1110 Aug 2026
Q4 FY26Jan–Mar 20261,261.59+22.4%420.45+45.0%25.5215 May 2026
Q3 FY26Oct–Dec 20251,177.51+16.5%307.85+4.3%18.6828 Jan 2026
Q2 FY26Jul–Sep 20251,074.15+1.1%302.00+7.2%18.3303 Nov 2025
Q1 FY26Apr–Jun 20251,038.84+2.6%269.26+20.8%16.3405 Aug 2025
Q4 FY25Jan–Mar 20251,030.35−12.3%290.00−9.8%17.6020 May 2025
Q3 FY25Oct–Dec 20241,010.78−7.9%295.12+6.6%17.9103 Feb 2025
Q2 FY25Jul–Sep 20241,062.99+5.2%281.71+9.4%17.1004 Nov 2024
Q1 FY25Apr–Jun 20241,012.02+14.5%222.92+18.8%13.5307 Aug 2024
Q4 FY24Jan–Mar 20241,174.83+49.6%321.41+305.8%19.5123 May 2024
Q3 FY24Oct–Dec 20231,097.86+18.6%276.81+21.7%16.8115 Feb 2024
Q2 FY24Jul–Sep 20231,010.67−3.6%257.53+7.5%15.6407 Nov 2023
Q1 FY24Apr–Jun 2023884.07+3.2%187.58−18.2%11.3907 Aug 2023
Q4 FY23Jan–Mar 2023785.42−28.8%79.21−72.3%4.8119 May 2023
Q3 FY23Oct–Dec 2022925.90−12.9%227.54−16.8%13.8224 Jan 2023
Q2 FY23Jul–Sep 20221,048.31−3.0%239.63−20.7%14.5527 Oct 2022
Q1 FY23Apr–Jun 2022856.90−25.7%229.45−34.6%13.9520 Jul 2022
Q4 FY22Jan–Mar 20221,103.01+24.2%285.98+9.8%17.4120 May 2022
Q3 FY22Oct–Dec 20211,063.33+23.7%273.38+33.9%16.6421 Jan 2022
Q2 FY22Jul–Sep 20211,080.47—302.12—18.3723 Oct 2021
Q1 FY22Apr–Jun 20211,153.90—350.68—21.4122 Jul 2021
Q4 FY21Jan–Mar 2021887.75—260.45—15.9318 May 2021
Q3 FY21Oct–Dec 2020859.42—204.11—12.8322 Jan 2021

45 filings on record for this company.